Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
118.21
-1.72 (-1.43%)
Nov 9, 2026, 4:00 PM EST - Market closed
Haemonetics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Haemonetics stock has a consensus rating of "Buy" and an average price target of $142.1. The average 1-year stock price forecast is 20.21% higher than the current stock price, while the lowest is $115 (-2.72%) and the highest is $165 (+39.58%).
Price Target: $142.1 (+20.21%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Haemonetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 3 | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 7, 2026 |
| Citi | Citi | Buy Maintains $123 → $149 | Buy | Maintains | $123 → $149 | +26.05% | Nov 6, 2026 |
| BTIG | BTIG | Buy Reiterates $130 → $142 | Buy | Reiterates | $130 → $142 | +20.13% | Nov 6, 2026 |
| Barrington | Barrington | Buy Maintains $140 → $145 | Buy | Maintains | $140 → $145 | +22.66% | Nov 6, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $140 → $165 | Buy | Maintains | $140 → $165 | +39.58% | Nov 6, 2026 |
Financial Forecast
Revenue This Year
1.44B
from 1.33B
Increased by 8.19%
Revenue Next Year
1.58B
from 1.44B
Increased by 9.46%
EPS This Year
5.33
from 4.96
Increased by 7.39%
EPS Next Year
6.19
from 5.33
Increased by 16.14%
EPS and Forward PE are based on non-GAAP adjusted numbers.